Revagenix

About:

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Website: https://www.revagenix.com

Top Investors: Novo Holdings, Tenmile, Repair Impact Fund

Description:

Total Funding Amount:

$4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Mateo, California, United States

Founded Date:

2019-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-01-05

IPO Status:

Private

Industries: